InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Versant Venture Capital VII, L.P.. Officer active across 1 company, notably Chinook Therapeutics, INC.. Cumulatively, 3 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €14.5m. Activity tracked since 27 August 2021. The latest transaction was filed on 4 April 2022 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Versant Venture Capital VII, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
709,953 shares0Common StockSEC:0000899243-22-014108:0
600,000 shares@ US$16.000258.2% of flowCommon StockSEC:0000899243-22-000946:0
510,000 shares@ US$14.0041.8% of flowCommon StockSEC:0000899243-21-034627:0
3 of 3 declarations
About Versant Venture Capital VII, L.P.
Versant Venture Capital VII, L.P. is a director at Chinook Therapeutics, INC.
